SUNNYVALE, Calif., Nov. 17, 2022 /PRNewswire/ — EBR Systems, Inc. (ASX: “EBR”, “EBR Systems”, or the “Company”), developer of the world’s solely wi-fi cardiac pacing system for coronary heart failure, is happy to announce that the Company’s WiSE^® expertise might be featured on the 15^th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in Singapore from the 18^th to the 20^th of November.

The APHRS is a number one non-profit organisation that represents medical, allied well being, and science professionals specialising in cardiac rhythm problems within the Asia-Pacific area. The annual convention is a premier occasion that includes trade workshops and a core scientific programme delivered by worldwide and regional audio system.

Five abstracts that includes WiSE^® have been accepted for shows, highlighting the expertise’s place on the forefront of innovation within the cardiac rhythm administration panorama. Abstracts that includes WiSE^® on the APHRS scientific session embody the next:

• Does Cardiac Resynchronisation Using WiSE^® – CRT Leadless Pacing Result in Greater QRS Shortening Than Conventional Resynchronisation? – Dr Simon James (James Cook University Hospital, UK)
• Feasibility of Totally Leadless CRT with Leadless Pacemaker and Leadless LV Endocardial Pacing System – Prof Pascal Defaye (Grenoble Alpes University Hospital, France)
• Leadless Left Bundle Branch Area Pacing: A Feasibility Study – Dr Mark Elliott (St Thomas’ Hospital, UK)
• The Effect of Electrode Location on Battery Longevity During Leadless LV Endocardial Pacing – Dr Mark Elliott (St Thomas’ Hospital, UK)
• The First Totally Leadless CRT System within the US – Dr Dinesh Sharma (NCH Heart Institute, USA)

John McCutcheon, EBR Systems’ President & Chief Executive Officer stated:
“We are excited to see our WiSE^® System continue to feature in leading conferences around the world. The abstracts presented at this scientific session strengthen the body of data supporting WiSE^® while promoting our technology to a wide audience including industry partners and the broader scientific community.”

About EBR Systems (ASX: EBR)

Silicon Valley-based EBR Systems (ASX: EBR) is devoted to superior therapy of cardiac rhythm illness by offering extra physiologically efficient stimulation via wi-fi cardiac pacing. The patented proprietary Wireless Stimulation Endocardially (WiSE) expertise was developed to eradicate the necessity for cardiac pacing leads, traditionally the main supply of issues and reliability points in cardiac rhythm illness administration. The preliminary product is designed to eradicate the necessity for coronary sinus results in stimulate the left ventricle in coronary heart failure sufferers requiring Cardiac Resynchronisation Therapy (CRT). Future merchandise probably handle wi-fi endocardial stimulation for bradycardia and different non-cardiac indications.

EBR Systems’ WiSE® Technology

EBR Systems’ WiSE expertise is the world’s solely wi-fi, endocardial (inside the center) pacing system in medical use for exciting the center’s left ventricle. This has lengthy been a objective of cardiac pacing corporations since inner stimulation of the left ventricle is considered a probably superior, extra anatomically appropriate pacing location. WiSE expertise allows cardiac pacing of the left ventricle with a novel cardiac implant that’s roughly the scale of a big grain of rice. The want for a pacing wire on the surface of the center’s left ventricle – and the attendant issues – are probably eradicated. WiSE is an investigational machine and isn’t at the moment obtainable on the market within the US.

SOURCE EBR Systems